Ventricular Tachycardia: Past, Present & Future
January 28, 2026
Author Sub-editor: Dr Justin Chiong Dr Justin Chiong is an NIHR Academic Clinical Fellow and Cardiology Registrar in the North West Deanery. He graduated from
Cardiovascular disease (CVD) and cancer are two major causes of mortality worldwide (1). Chemotherapeutic agents have come a long way and the advent of targeted therapies has ushered in a new era of personalised cancer care which, along with risk factor reduction, have shown a decline in cancer mortality (2, 3). As cancer survival improves, the burden of CVD becomes more apparent (4). The Surveillance, Epidemiology and End Results (SEER) database showed that the risk of mortality from CVD was greatest in the first year of cancer diagnosis and patients diagnosed under 55 years old had a ten-fold risk of CVD related death compared to the general population (5).
Author Sub-editor: Dr Justin Chiong Dr Justin Chiong is an NIHR Academic Clinical Fellow and Cardiology Registrar in the North West Deanery. He graduated from
Author Sub-editor: Dr Hnin Zaw Dr Hnin Zaw is a cardiology registrar from the East of England Deanery with a specialist interest in electrophysiology and
Author Sub-editor: Dr Tha Htet Nyi Dr Tha Htet Nyi is a cardiology registrar in South London Deanery with subspecialty interests in multimodal cardiac imaging and
Author Sub-editor: Dr Chi Ho Fung Dr Chi Ho Fung graduated with Distinction from Imperial College School of Medicine in 2019 with an Intercalated Bachelor
Authors Heartbeat Sub-Editor: Alexandar Drampalou I am Dr.Alexandar Drampalou ,a cardiologist currently specializing in cardiac magnetic resonance (CMR) at Guy’s and St Thomas’ Hospital and
Authors Heartbeat Sub-Editor: Marina Zafeiri Dr Marina Zafeiri is an IMT3 in the Wessex deanery, with a strong interest in Cardiology. She graduated from Athens